scholarly article | Q13442814 |
P50 | author | Anna Bershteyn | Q89475473 |
Stephen B Asiimwe | Q96162393 | ||
Katherine K Thomas | Q104105000 | ||
Meighan L Krows | Q108887345 | ||
Torin T Schaafsma | Q108887352 | ||
Bosco Turyamureeba | Q117266732 | ||
Heidi van Rooyen | Q42571461 | ||
Alastair van Heerden | Q42571761 | ||
Connie Celum | Q42571941 | ||
Adrienne E Shapiro | Q57873814 | ||
Deenan Pillay | Q57899870 | ||
Norma C Ware | Q58413480 | ||
Monique A Wyatt | Q88720656 | ||
Ruanne Barnabas | Q89357484 | ||
Jared M Baeten | Q89443633 | ||
P2093 | author name string | Susan Morrison | |
Philip Joseph | |||
Adam A Szpiro | |||
Peter Ehrenkranz | |||
Olivier Koole | |||
Maryam Shahmanesh | |||
Kombi Sausi | |||
Nsika Sithole | |||
D Allen Roberts | |||
Delivery Optimization of Antiretroviral Therapy (DO ART) Study Team | |||
P2860 | cites work | Prevention of HIV-1 infection with early antiretroviral therapy | Q24634688 |
Engagement in care, viral suppression, drug resistance and reasons for non-engagement after home-based same-day ART initiation in Lesotho: a two-year follow-up of the CASCADE trial | Q91536044 | ||
Which community-based HIV initiatives are effective in achieving UNAIDS 90-90-90 targets? A systematic review and meta-analysis of evidence (2007-2018) | Q91958089 | ||
Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART) | Q91960305 | ||
Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa | Q92121447 | ||
Community-Based ART Programs: Sustaining Adherence and Follow-up | Q28079097 | ||
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis | Q34067511 | ||
Engaging men in prevention and care for HIV/AIDS in Africa | Q34162204 | ||
A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa | Q34583843 | ||
Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission | Q34920252 | ||
Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013 | Q35576031 | ||
Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. | Q36233895 | ||
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review | Q36414972 | ||
Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). | Q37247477 | ||
Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study | Q37503472 | ||
Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa | Q37659139 | ||
Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study | Q38403923 | ||
Expanding HIV testing and linkage to care in southwestern Uganda with community health extension workers | Q38849415 | ||
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda | Q38869763 | ||
Rates of HIV testing and diagnosis in South Africa: successes and challenges | Q40820046 | ||
Improved Retention with Six Month Clinic Return Intervals for Stable HIV-Infected Patients in Zambia | Q41987081 | ||
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial | Q47589510 | ||
Factors Associated With Poor Linkage to HIV Care in South Africa: Secondary Analysis of Data From the Thol'impilo Trial | Q47624961 | ||
Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys | Q56909157 | ||
Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up | Q57707551 | ||
Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania | Q57970335 | ||
STACKing the odds for adolescent survival: health service factors associated with full retention in care and adherence amongst adolescents living with HIV in South Africa | Q57985970 | ||
Differentiated service delivery: navigating the path to scale | Q58549366 | ||
Community-based HIV prevalence in KwaZulu-Natal, South Africa: results of a cross-sectional household survey | Q60920275 | ||
The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case | Q64102807 | ||
P433 | issue | 10 | |
P921 | main subject | Uganda | Q1036 |
randomized experiment | Q1231081 | ||
P304 | page(s) | e1305-e1315 | |
P577 | publication date | 2020-10-01 | |
P1433 | published in | The Lancet Global Health | Q27667673 |
P1476 | title | Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial | |
P2283 | uses | randomized experiment | Q1231081 |
P478 | volume | 8 |
Q99708021 | The where, when, and how of community-based versus clinic-based ART delivery in South Africa and Uganda | cites work | P2860 |
Search more.